Response Oncology, Inc. Stock

Equities

ROIX

US7612323052

Healthcare Facilities & Services

Market Closed - OTC Markets 09:30:50 2023-08-22 EDT 5-day change 1st Jan Change
0.000001 USD -.--% Intraday chart for Response Oncology, Inc. -.--% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2000 131M 178M Sales 2001 118M 161M Capitalization 676K 920K
Net income 2000 -14M -19.05M Net income 2001 -51M -69.41M EV / Sales 2000 0.24 x
Net Debt 2000 27.76M 37.78M Net Debt 2001 18.62M 25.35M EV / Sales 2001 0.16 x
P/E ratio 2000
-0.21 x
P/E ratio 2001
-0.01 x
Employees -
Yield 2000 *
-
Yield 2001
-
Free-Float 99.22%
More Fundamentals * Assessed data
Dynamic Chart
5 years
0.00
Extreme 0
0.00
10 years
0.00
Extreme 0
0.00
More quotes
Response Oncology, Inc. was, prior to the sales of its assets, a comprehensive cancer management company. As of May 20, 2002, the Company had liquidated substantially all of its operating assets and anticipates that the remaining assets will be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, the Company provided advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the non-medical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW